MedPath

The Effect Of Anaerobic Exercise On Bone Morphogenetic Protein 9

Conditions
Healthy
Exercise
Interventions
Other: Physiological test
Other: Physical test
Other: Biochemical tests
Registration Number
NCT05117437
Lead Sponsor
Ege University
Brief Summary

Bone morphogenetic protein (BMP) 9 from the BMP family has an important role in the remodeling of bone and cartilage. Due to these features, BMP9 can play an important role in especially anaerobic exercise training adaptations. However, the role of anaerobic exercise in these effects is still unclear. The aim of this study is to investigate the role of BMP9 on the effects of acute and chronic anaerobic exercise on bone metabolism markers. Postprandial venous blood samples were taken pre- and post- acute YOYO intermittent recovery test (level 1) in 40 trained male athletes aged 18-35 who did anaerobic sports (such as basketball, volleyball and handball) and 41 sedentary volunteers aged 18-35. Serum BMP9, as markers of bone formation and resorption; alkaline phosphatase (ALP), C-terminal telopeptide of type 1 collagen (CTX1), cartilage oligomeric matrix protein (COMP) and calcium levels were determined. The data to be obtained as a result of our study can give information about the relationship between the skeletal and bone health of the athletes and anaerobic exercise.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
81
Inclusion Criteria
  • being male
  • having a body mass index of less than 30 being
Exclusion Criteria
  • to have some disease or disability
  • to regularly use cigarettes and alcohol
  • to use any medication or antioxidant substance

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Athletic groupPhysiological testHealthy male athletes who have been doing regular anaerobic sports (such as basketball, volleyball and handball) for at least 3 months
Control groupPhysical testHealthy sedentary (not doing regular sports for at least 3 months) men with age and physical characteristics similar to the athlete group
Athletic groupBiochemical testsHealthy male athletes who have been doing regular anaerobic sports (such as basketball, volleyball and handball) for at least 3 months
Control groupPhysiological testHealthy sedentary (not doing regular sports for at least 3 months) men with age and physical characteristics similar to the athlete group
Athletic groupPhysical testHealthy male athletes who have been doing regular anaerobic sports (such as basketball, volleyball and handball) for at least 3 months
Control groupBiochemical testsHealthy sedentary (not doing regular sports for at least 3 months) men with age and physical characteristics similar to the athlete group
Primary Outcome Measures
NameTimeMethod
Change from serum CTX1 levels at pre- and post- YOYO intermittent testbetween 40-50 minutes

Postprandial venous blood samples were obtained before and after acute YOYO IR test (level 1). The YOYO test lasted 10-20 minutes depending on the ability level of the participants. A blood sample was taken 15 minutes before and 15 minutes after the YOYO test. From these blood samples, serum C-terminal telopeptide of Type 1 collagen (CTX1) was determined.

Change from serum BMP9 levels at pre- and post- YOYO intermittent testbetween 40-50 minutes

Postprandial venous blood samples were obtained before and after acute YOYO IR test (level 1). The YOYO test lasted 10-20 minutes depending on the ability level of the participants. A blood sample was taken 15 minutes before and 15 minutes after the YOYO test. From these blood samples, serum Bone morphogenetic protein 9 (BMP9) was determined.

Change from serum COMP levels at pre- and post- YOYO intermittent testbetween 40-50 minutes

Postprandial venous blood samples were obtained before and after acute YOYO IR test (level 1). The YOYO test lasted 10-20 minutes depending on the ability level of the participants. A blood sample was taken 15 minutes before and 15 minutes after the YOYO test. From these blood samples, serum cartilage oligomeric matrix protein (COMP) was determined.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ege University Faculty of Sport Sciences

🇹🇷

İzmir, Turkey

© Copyright 2025. All Rights Reserved by MedPath